We are live on ! Find out more
JNJ icon

Johnson & Johnson

1,976 hedge funds and large institutions have $198B invested in Johnson & Johnson in 2014 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 732 increasing their positions, 972 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 41

8% more capital invested

Capital invested by funds: $185B → $198B (+$13.9B)

2% more funds holding in top 10

Funds holding in top 10: 675688 (+13)

0.49% more ownership

Funds ownership: 66.51%67% (+0.49%)

0% more funds holding

Funds holding: 1,9731,976 (+3)

25% less repeat investments, than reductions

Existing positions increased: 732 | Existing positions reduced: 972

26% less call options, than puts

Call options by funds: $1.09B | Put options by funds: $1.48B

Holders
1,976
Holders Change
+3
Holders Change %
+0.15%
% of All Funds
56.77%
Holding in Top 10
688
Holding in Top 10 Change
+13
Holding in Top 10 Change %
+1.93%
% of All Funds
19.76%
New
54
Increased
732
Reduced
972
Closed
41
Calls
$1.09B
Puts
$1.48B
Net Calls
-$385M
Net Calls Change
-$512M
Name Holding Trade Value Shares
Change
Change in
Stake
HDIM
1501
Hanson & Doremus Investment Management
Vermont
$1.47M -$8.09K -80 -0.6%
AB
1502
AT Bancorp
Iowa
$1.47M -$12.5K -124 -0.9%
BGDI
1503
BW Gestao de Investimentos
Brazil
$1.47M
TCCM
1504
Timber Creek Capital Management
Massachusetts
$1.46M -$68.3K -676 -5%
CFMC
1505
Curbstone Financial Management Corp
New Hampshire
$1.46M -$30.3K -300 -2%
FFC
1506
First Financial Corp
Indiana
$1.45M -$5.56K -55 -0.4%
WIS
1507
Wright Investors Service
Connecticut
$1.45M +$282K +2,790 +25%
SIC
1508
SFE Investment Counsel
California
$1.44M -$41.4K -410 -3%
EFSCE
1509
Enterprise Financial Services Corp (EFSC)
Missouri
$1.43M +$265K +2,626 +24%
PPCM
1510
Pillar Pacific Capital Management
California
$1.42M -$35.9K -355 -3%
SAMC
1511
Shinko Asset Management Company
Japan
$1.42M -$724K -7,160 -35%
CHJWM
1512
Carlton Hofferkamp & Jenks Wealth Management
Texas
$1.41M -$374K -3,699 -21%
HCM
1513
Hutchinson Capital Management
California
$1.41M -$12.8K -127 -0.9%
BOS
1514
Bank of Stockton
California
$1.41M +$103K +1,018 +8%
FLPIM
1515
F.L. Putnam Investment Management
Massachusetts
$1.41M -$456K -4,514 -25%
KFA
1516
Kelleher Financial Advisors
New York
$1.4M
ITIM
1517
Indiana Trust & Investment Management
Indiana
$1.4M +$58.5K +579 +5%
CCA
1518
Checchi Capital Advisers
California
$1.4M +$270K +2,669 +25%
KCM
1519
KSA Capital Management
New Jersey
$1.39M
SKK
1520
Shepherd Kaplan Krochuk
Massachusetts
$1.39M -$123K -1,218 -8%
BCM
1521
Brookstone Capital Management
Illinois
$1.39M +$121K +1,194 +10%
ADMI
1522
Albert D. Mason Inc
Massachusetts
$1.38M -$152K -1,500 -10%
MWM
1523
Modera Wealth Management
New Jersey
$1.37M +$29K +287 +2%
FA
1524
Fagan Associates
New York
$1.37M -$38.9K -385 -3%
PG
1525
Proffitt & Goodson
Tennessee
$1.35M -$46K -455 -3%

JNJ Hedge Fund Activity: Q2 2014 in Review

1,976 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2014, worth a combined $198B — up 7.5% from $185B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new JNJ positions and 41 closed out — a net gain of 13 holders — while 732 added to existing stakes and 972 trimmed.

The largest buyer was Norges Bank, adding an estimated $2.09B. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $331M.

  • 1,976 institutional investors held Johnson & Johnson (JNJ) as of Q2 2014, up from 1,973 in Q1 2014.
  • Funds reported $198B of Johnson & Johnson stock for Q2 2014, up 7.5% quarter-over-quarter.
  • 54 funds opened new Johnson & Johnson positions in Q2 2014 and 41 closed out, a net change of +13 holders.
  • The largest Johnson & Johnson buyer in Q2 2014 was Norges Bank, an estimated $2.09B added.
  • The largest Johnson & Johnson seller in Q2 2014 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $331M sold.

Based on aggregated 13F filings for Q2 2014.